NASDAQ (usa) arrow 6715.56 -12.11 -0.18%
FTSE 100 (london) arrow 7487.96 -5.12 -0.07%
DAX (german) arrow 13465.51 235.94 1.78%
NIKKEI 225 (japan) arrow 22420.08 408.47 1.86%
Hang - Seng (hong kong) arrow 28594.06 348.52 1.23%
NIFTY - 50 (india)
Straits Times (singapore) arrow 3391.61 17.53 0.52%
KOSPI (korea) arrow 2556.47 33.04 1.31%
All Ordinaries (australia) arrow 6005.30 28.90 0.48%
BOVESPA (brazil) arrow 74092.76 -215.73 -0.29%

Cortexyme Inc (NASDAQ: CRTX)

 
CRTX Technical Analysis
5
As on 26th Nov 2021 CRTX Share Price closed @ 12.03 and we RECOMMEND Strong Sell for LONG-TERM with Stoploss of 47.65 & Strong Sell for SHORT-TERM with Stoploss of 46.42 we also expect STOCK to react on Following IMPORTANT LEVELS.
 
 

CRTX Share Price

Open 12.02 Change Price %
High 12.07 1 Day -0.19 -1.55
Low 11.54 1 Week -2.66 -18.11
Close 12.03 1 Month -61.81 -83.71
Volume 535080 1 Year -37.44 -75.68
52 Week High 120.21 | 52 Week Low 12.03
 
NASDAQ USA Most Active Stocks
AAL 17.75 -8.79%
AAPL 156.81 -3.17%
ISPC 17.51 71.67%
SNDL 0.65 -4.41%
AHPI 8.32 54.65%
LCID 51.72 -1.62%
BIMI 0.90 28.57%
UAL 42.26 -9.57%
AMD 154.81 -1.89%
MRNA 329.63 20.57%
 
NASDAQ USA Top Gainers Stocks
ZWZZT 46.00 142.11%
NRXPW 3.10 78.16%
ISPC 17.51 71.67%
AHPI 8.32 54.65%
NRXP 6.75 50.00%
ATMH 0.16 45.45%
VOSOU 15.61 42.04%
ADGI 25.12 34.12%
PHIOW 0.04 33.33%
BOWXW 2.97 29.13%
 
NASDAQ USA Top Losers Stocks
IFMK 0.02 -93.10%
PTRAW 0.23 -89.59%
TPGY-WT 1.72 -83.65%
SGOC 5.37 -54.49%
STMP 0.02 -33.33%
STMP 0.02 -33.33%
CTXRW 0.40 -28.57%
SGAMU 10.45 -27.93%
LGVN 30.67 -27.49%
NOVVR 0.40 -25.93%
 
 
CRTX
Daily Charts
CRTX
Intraday Charts
Whats New @
Bazaartrend
CRTX
Free Analysis
 
CRTX Important Levels Intraday
RESISTANCE13.05
RESISTANCE12.72
RESISTANCE12.52
RESISTANCE12.32
SUPPORT11.74
SUPPORT11.54
SUPPORT11.34
SUPPORT11.01
 
CRTX Target for Month November
4th UP TARGET73.54
3rd UP TARGET53.81
2nd UP TARGET41.62
1st UP TARGET29.43
1st DOWN TARGET-5.37
2nd DOWN TARGET-17.56
3rd DOWN TARGET-29.75
4th DOWN TARGET-49.48
 
CRTX Weekly Target
4th UP TARGET18.00
3rd UP TARGET16.09
2nd UP TARGET14.90
1st UP TARGET13.72
1st DOWN TARGET10.34
2nd DOWN TARGET9.16
3rd DOWN TARGET7.97
4th DOWN TARGET6.06
 
CRTX Target for Year 2021
4th UP TARGET224.85
3rd UP TARGET156.6
2nd UP TARGET114.41
1st UP TARGET72.22
1st DOWN TARGET-48.16
2nd DOWN TARGET-90.35
3rd DOWN TARGET-132.54
4th DOWN TARGET-200.79
 
 
CRTX Other Details
Segment EQ
Market Capital 423319520.00
Sector Healthcare
Industry Biotechnology
Offical website >
 
CRTX Address
CRTX
 
CRTX Latest News
 
Your Comments and Response on Cortexyme Inc
 
CRTX Business Profile
Cortexyme, Inc., a clinical stage biopharmaceutical company, focuses on developing therapeutics for Alzheimer's disease and other degenerative disorders. Its lead drug candidate is atuzaginstat (COR388), an orally administered brain-penetrating small molecule gingipain inhibitor, which is in Phase II/III clinical trial for use in patients with mild to moderate Alzheimer's disease. Cortexyme, Inc. has a partnership with Parkinson Study Group. The company was incorporated in 2012 and is headquartered in South San Francisco, California. Address: 269 East Grand Avenue, South San Francisco, CA, United States, 94080
 
2005-2021 BazaarTrend.com All rights reserved.

Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service